Discussing the Coronavirus- Part 1

Share the Truth!
Share on facebook
Facebook
Share on twitter
Twitter
Share on google
Google
The Coronavirus needs no introduction, by now everyone has heard about it! If you want to learn more and hear the truth watch these videos!

Want to share a short clip of power information to a family member or friend from this show? Click here! Is the Current Coronavirus Patented and Did a Laboratory Create a Bat Coronavirus?

Related Videos:

Discussing the Coronavirus- Part 2 https://thewilddoc.com/discussing-the-coronavirus-part-2/ Discussing the Coronavirus- Part 3 https://thewilddoc.com/discussing-the-coronavirus-part-3/

Resources / References:

Coronavirus Infections—More Than Just the Common Cold https://jamanetwork.com/journals/jama/fullarticle/2759815?guestAccessKey=26c81797-556e-4583-b052-3639ca5b0e95&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jama&utm_term=mostread&utm_content=olf-widget_01242020 Coronavirus – Patent https://patents.justia.com/patent/10130701?fbclid=IwAR3wV4fO2pyCknHEO6ojybglxz5K9dN1KvIQrCff5qV_8Be6GWqU4SKyrNE Coronavirus may have originated in lab linked to China’s biowarfare program https://www.washingtontimes.com/news/2020/jan/26/coronavirus-link-china-biowarfare-program-possible/?fbclid=IwAR0LNqpKJ5sF_4JRZT9z90Wskb1dHRNhe-Uf-g0eDBmFY6JlqC0Q9o5S_pk Event 201 Pandemic Exercise: Highlights Reel https://www.youtube.com/watch?v=AoLw-Q8X174&fbclid=IwAR34oQDP72zJlpjdqpl39cT78K7nyoXETmkdLAdnmhHk4Vl3sDrcs11VeDc Lab-Made Coronavirus Triggers Debate The creation of a chimeric SARS-like virus has scientists discussing the risks of gain-of-function research. https://www.the-scientist.com/news-opinion/lab-made-coronavirus-triggers-debate-34502?fbclid=IwAR065OVxbeNic8MViplvO60r4KIAgPIbiMDupzrb2OvXcoCdSc_37lAeZlo Vaccine for new Chinese coronavirus in the works https://www.cnn.com/2020/01/20/health/coronavirus-nih-vaccine-development/index.html?fbclid=IwAR17p3ayL0ygPqlvbn1XwYu8s1fO7phh32QudA5rNR2l7R2xS_QZbgjmMLw Increased Risk of Noninfluenza Respiratory Virus Infections Associated With Receipt of Inactivated Influenza Vaccine https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404712/ Assessment of temporally-related acute respiratory illness following influenza vaccination – https://www.ncbi.nlm.nih.gov/pubmed/29525279 LIVE | Schumer wants the feds to declare Coronavirus a public health emergency now so the CDC can have more funds at the ready. https://www.facebook.com/ABC7NY/videos/861390570997920/ A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon Challenge https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3209347/ Prior Immunization with Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected with SARS-CoV https://www.researchgate.net/publication/23403209_Prior_Immunization_with_Severe_Acute_Respiratory_Syndrome_SARS-Associated_Coronavirus_SARS-CoV_Nucleocapsid_Protein_Causes_Severe_Pneumonia_in_Mice_Infected_with_SARS-CoV Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus  https://www.ncbi.nlm.nih.gov/pubmed/22536382 US health officials fast-track coronavirus vaccine, hope to start clinical trial in three months https://www.cnbc.com/2020/01/28/us-fast-tracks-coronavirus-vaccine-hopes-to-start-trial-in-three-months.html?fbclid=IwAR3GFZwU8UJf5Wrp0TJh8REIdv7N1Rfd8eCSqO4PjrVqqtQKoP1prTn66X4 The increasing incidence and prevalence of eosinophilic esophagitis outpaces changes in endoscopic and biopsy practice: National population-based estimates from Denmark https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504237/ Incidence and Prevalence of Eosinophilic Esophagitis in Children https://journals.lww.com/jpgn/Fulltext/2013/07000/Incidence_and_Prevalence_of_Eosinophilic.16.aspx Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus https://www.ncbi.nlm.nih.gov/pubmed/21310191 Critics slam treatment for SARS as ineffective and perhaps dangerous https://www.nature.com/articles/423004a?error=cookies_not_supported&code=c2ec0221-8d5d-4584-9d2f-84044a28ee0d WHO says SARS outbreak is over, but fight should go on https://www.bmj.com/rapid-response/2011/10/29/traditional-chinese-medicine-treatment-sars Can herbal medicine assist against avian flu? Learning from the experience of using supplementary treatment with Chinese medicine on SARS or SARS-like infectious disease in 2003. https://www.ncbi.nlm.nih.gov/pubmed/16884338 Sambucus nigra extracts inhibit infectious bronchitis virus at an early point during replication https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899428/ Lonicera japonica Thunb.: Ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine https://www.sciencedirect.com/science/article/abs/pii/S0378874111005897 Small molecules targeting severe acute respiratory syndrome human coronavirus https://www.ncbi.nlm.nih.gov/pmc/articles/PMC454157/ Antiviral effects of Glycyrrhiza species https://onlinelibrary.wiley.com/doi/abs/10.1002/ptr.2295 Identification of Natural Compounds with antiviral activities against SARS-associated coronavirus https://www.ncbi.nlm.nih.gov/pubmed/15885816 Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085190/ Natural Bis-Benzylisoquinoline Alkaloids-Tetrandrine, Fangchinoline, and Cepharanthine, Inhibit Human Coronavirus OC43 Infection of MRC-5 Human Lung Cells. https://www.ncbi.nlm.nih.gov/pubmed/31690059 Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction https://www.sciencedirect.com/science/article/abs/pii/S0166354206001215
Share the Truth!
Share on facebook
Facebook
Share on twitter
Twitter
Share on google
Google

Leave a Reply

Your email address will not be published. Required fields are marked *